Prices delayed by at least 15 minutes | Print
BioLife Solutions (BLFS)
Common SharesOpen
$17.68
Previous close
$17.54
Trade high
$18.15
Volume
478,834
Year high
$24.50
Year low
$8.92
Dividend yield
-
Market capitalisation
$791.84 mn
P/E ratio
238.10
ISIN
US09062W2044
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Company profile
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freezemedia products for cells, tissues, and organs.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.